Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
1R29DE011772-01
Application #
2133160
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Project Start
1996-04-01
Project End
2001-03-30
Budget Start
1996-04-01
Budget End
1997-03-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Otolaryngology
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Day, K V; Li, D; Liu, S et al. (2001) Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer. Laryngoscope 111:801-6
Li, D; Duan, L; Freimuth, P et al. (1999) Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res 5:4175-81
O'Malley Jr, B W; Sewell, D A; Li, D et al. (1997) The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer. Mol Endocrinol 11:667-73
Sewell, D A; Li, D; Duan, L et al. (1997) Optimizing suicide gene therapy for head and neck cancer. Laryngoscope 107:1490-5
Sewell, D A; Li, D; Duan, L et al. (1997) Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer. Arch Otolaryngol Head Neck Surg 123:1298-302